首頁 > 市場調查報告書 > 醫療設備

心血管設備

心臟節律管理設備市場規模、佔有率及成長分析（按產品、最終用戶及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899431

心臟節律管理設備市場規模、佔有率及成長分析（按產品、最終用戶及地區分類）－2026-2033年產業預測

Cardiac Rhythm Management Devices Market Size, Share, and Growth Analysis, By Product (Pacemakers [Implantable, External]), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，心臟節律管理設備市場規模將達到 209.2 億美元，到 2025 年將達到 220.7 億美元，到 2033 年將達到 338.7 億美元，預測期（2026-2033 年）的複合年成長率為 5.5%。

心血管疾病盛行率的不斷上升以及全球治療手術數量的增加，預計將顯著推動心臟節律管理設備的銷售。在心臟研發投入不斷成長的推動下，技術的創新進步可望進一步提升市場前景。遠端監測和遠端醫療醫療的日益普及也將進一步刺激對這些設備的需求。此外，新興市場醫療費用支出的成長以及對醫療基礎設施建設的日益重視，將為產業相關人員創造新的機會。微創心血管手術的趨勢也將促進此類設備的更廣泛應用。然而，電池續航力有限、設備更換需求、故障風險以及新興地區認知度較低等挑戰，可能會阻礙市場的成長潛力。

心臟節律管理設備市場促進因素

患者對微創心血管手術的偏好顯著提升，這對心臟節律管理設備市場產生了積極影響。這種對微創治療方案日益成長的需求與心臟節律管理技術的進步相契合。透過微創技術植入這些設備將更加便捷，預計這將隨著時間的推移顯著提升市場需求。隨著患者對能夠最大限度減少不適感和縮短恢復期的治療方法方案的需求不斷成長，心臟節律管理設備市場有望受益於以患者為中心、高效治療方法的持續發展趨勢。

心臟節律管理設備市場的限制因素

由於設備故障和失效的風險，心臟節律管理設備市場面臨嚴峻挑戰，這會削弱患者的信心，並導致監管機構加強審查。這些問題不僅加劇了患者對這些技術可靠性的擔憂，還可能阻礙未來的銷售前景。隨著監管機構著手解決這些問題並實施更嚴格的指導方針和監管，人們對心臟節律管理解決方案的整體信心可能會下降，進一步影響市場成長和普及。解決這些薄弱環節對於維持產業發展動能至關重要。

心臟節律管理設備市場趨勢

心臟節律管理設備市場日益關注改善心臟衰竭患者的治療效果，這主要得益於其監測關鍵生理參數（例如體液儲存）的能力。這項創新技術使醫療專業人員能夠更有效地追蹤心臟健康狀況，從而及時進行干預，防止心臟衰竭進展並降低死亡率。人們對早期發現和管理心臟相關疾病重要性的認知不斷提高，預計將增加對心臟護理領域先進監測解決方案的需求。這有望推動市場成長，並促進設備功能和患者管理策略的創新。

心律調節器
- 可植入式
- 外部的
去心房顫動
- 植入式心臟整流去顫器（ICD）
- S-ICD
- T-ICD
- 體外去心房顫動
- 手動體外心臟去心房顫動
- 自動體外心臟去心房顫動
- 穿戴式去心房顫動
- 心臟再同步治療（CRT）
- CRT去心房顫動
- CRT心律調節器

按最終用戶分類的心臟節律管理設備市場

醫院和診所
門診手術中心
其他

按地區分類的心臟節律管理設備市場規模

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Physio-Control, Inc.（Stryker）（US）
BIOTRONIK（Germany）
Schiller（Switzerland）
Medtronic（US）
Abbott（US）
Koninklijke Philips NV（Netherlands）
Zoll Medical Corporation（US）
Boston Scientific Corporation（US）
Progetti Srl（Italy）
LivaNova Plc（UK）
Impella（ABIOMED, US）
AngioDynamics, Inc.（US）
MicroPort Scientific Corporation（China）
Edwards Lifesciences Corporation（US）
Getinge AB（Sweden）
Synchrony Medical（US）
Osypka AG（Germany）
Inspire Medical Systems, Inc.（US）
AtriCure, Inc.（US）
Apex Medical（Taiwan）
Biotronik SE & Co. KG（Germany）
VivaSonic Inc.（US）

簡介目錄

Product Code: SQMIG35A2577

Cardiac Rhythm Management Devices Market size was valued at USD 20.92 Billion in 2024 and is poised to grow from USD 22.07 Billion in 2025 to USD 33.87 Billion by 2033, growing at a CAGR of 5.5% during the forecast period (2026-2033).

The increasing prevalence of cardiovascular disorders, coupled with a rising number of treatment procedures globally, is anticipated to significantly boost sales of cardiac rhythm management devices. Innovative advancements in technology, driven by heightened investment in cardiac research and development, are likely to enhance market prospects. The growing adoption of remote monitoring and telehealth practices will further stimulate demand for these devices. Additionally, increased healthcare spending and a focus on healthcare infrastructure improvements in emerging markets will create new opportunities for industry players. The trend towards minimally invasive cardiac procedures will also facilitate broader adoption. However, challenges such as battery limitations, device replacement needs, malfunction risks, and low awareness in emerging regions may hinder market growth potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiac Rhythm Management Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiac Rhythm Management Devices Market Segments Analysis

Global Cardiac Rhythm Management Devices Market is segmented by Product, End User, and region. Based on Product, the market is segmented into Pacemakers, and Defibrillators. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgery Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiac Rhythm Management Devices Market

There has been a notable shift towards a preference for minimally invasive cardiac procedures among patients, which positively impacts the cardiac rhythm management devices sector. This growing inclination towards less invasive options aligns seamlessly with the advancements in cardiac rhythm management technologies. The ability to easily implant these devices through minimally invasive methods is anticipated to significantly enhance their demand over time. As patients increasingly seek out solutions that minimize discomfort and recovery time, the market for cardiac rhythm management devices is expected to benefit from this ongoing trend towards more patient-centric and efficient treatment options.

Restraints in the Cardiac Rhythm Management Devices Market

The cardiac rhythm management devices market faces significant challenges due to the risk of device failures and malfunctions, which can undermine patient confidence and lead to increased regulatory scrutiny. Such issues not only contribute to apprehension among patients regarding the reliability of these technologies but may also hinder future sales prospects. As regulatory bodies impose stricter guidelines and oversight in response to these concerns, the overall trust in cardiac rhythm management solutions may diminish, further impacting market growth and adoption rates. Addressing these vulnerabilities is crucial for sustaining momentum within the industry.

Market Trends of the Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices market is increasingly focusing on enhancing patient outcomes for those with heart failure, driven by the capability of these devices to monitor critical physiological parameters, such as fluid accumulation. This innovative technology allows healthcare professionals to track cardiac health more effectively, leading to timely interventions that can prevent the progression of heart failure and reduce mortality rates. As awareness grows regarding the importance of early detection and management of heart-related issues, the demand for advanced monitoring solutions in cardiac care is expected to rise, thereby propelling market growth and driving innovations in device functionality and patient management strategies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Cardiac Rhythm Management Devices Market by Product

Market Overview
Pacemakers
- Implantable
- External
Defibrillators
- Implantable Cardioverter Defibrillators (ICD)
- S-ICD
- T-ICD
- External Defibrillator
- Manual External Defibrillator
- Automatic External Defibrillator
- Wearable Cardioverter Defibrillator
- Cardiac Resynchronization Therapy (CRT)
- CRT-Defibrillator
- CRT-Pacemakers

Cardiac Rhythm Management Devices Market by End User

Market Overview
Hospitals & Clinics
Ambulatory Surgery Centers
Others

Cardiac Rhythm Management Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Physio-Control, Inc. (Stryker) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIOTRONIK (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schiller (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zoll Medical Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progetti Srl (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova Plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Impella (ABIOMED, US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synchrony Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inspire Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AtriCure, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apex Medical (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VivaSonic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments